Li Ma from 6310 SW 91St Ave, Miami, FL 33173, age 46

Lawyers & Attorneys

Li Ma - Lawyer

view source

ISLN:

900018174

Admitted:

1992

University:

Beijing University, 1991

License Records

Li Zhi Ma

License #:

="25570" - Active

Issued Date:

Jun 8, 2007

Renew Date:

Sep 9, 2015

Expiration Date:

Nov 30, 2017

Type:

Certified Public Accountant

Li Ma

License #:

E114933 - Active

Category:

Emergency medical services

Issued Date:

Jun 30, 2015

Expiration Date:

Jun 30, 2017

Type:

Los Angeles County EMS Agency

Medicine Doctors

Li Ma

view source

Specialties:

Anesthesiology, Pain Management

Work:

Interventional Pain Physicians
5304 Main St, New Port Richey, FL 34652
(727)5978430 (phone), (727)5978431 (fax)

Education:

Medical School
Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71)
Graduated: 1988

Languages:

English
Spanish

Description:

Dr. Ma graduated from the Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71) in 1988. She works in New Port Richey, FL and specializes in Anesthesiology and Pain Management.

Li Ma

view source

Specialties:

Anatomic Pathology & Clinical Pathology

Work:

Southeastern Pathology Associates
203 Indigo Dr, Brunswick, GA 31525
(912)2612669 (phone), (912)2610561 (fax)

Education:

Medical School
Xuzhou Med Coll, Xuzhou City, Jiangsu, China
Graduated: 1982

Languages:

English

Description:

Dr. Ma graduated from the Xuzhou Med Coll, Xuzhou City, Jiangsu, China in 1982. He works in Brunswick, GA and specializes in Anatomic Pathology & Clinical Pathology.

Li Ma

view source

Us Patents

Compositions And Methods Relating To Induction Of Intestinal Stem Cell Homeogenesis And/Or Regeneration
view source
US Patent:

20160000865, Jan 7, 2016
Filed:

Feb 25, 2014
Appl. No.:

14/770044
Inventors:

- Ann Arbor MI, US
Wei-Jie Zhou - Ann Arbor MI, US
Li Ma - Saline MI, US
Assignee:

The Regents of the University of Michigan - Ann Arbor MI
International Classification:

A61K 38/17
Abstract:

The present invention relates to compositions and methods for inducing intestinal stem cell homeogenesis and/or regeneration within intestinal tissue expressing Robo1 through administration of a Rspo1 agent and a Slit2 agent. Administration of such agents results in, for example, binding of the Rspo1 agent and Slit2 agent with Robo1, resulting in, for example, binding of the CC3 motif of Robo1 with LRP6, resulting in phosphorylation of LRP6, and ultimately, induction of intestinal stem cell homeogenesis and/or regeneration. In certain embodiments, such administration of a Rspo1 agent and a Slit2 agent is used to protect and/or prevent intestinal tissue damage resulting from exposure to an intestinal tissue damaging event (e.g., radiation). The agents and related compositions additionally find use in diagnostic and research settings.